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Identity 
Other names: EBP50; NHERF; NHERF1; NPHLOP2 




The SLC9A3R1 gene is comprised of 6 exons and 
spans approximately 20.7 kb of genomic DNA. 
Transcription 
The SLC9A3R1 gene encodes a 1978 bp mRNA 
transcript. 
Reported regulatory transcription factor binding sites 
upstream of the SLC9A3R1 promoter region include: 
NF-kappaB1, HNF-4alpha2, COUP-TF1, NF-kappaB, 








DNA size 20.71 Kb; mRNA size 1978 bp; 6 exons. 
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The SLC9A3R1 protein is composed of 353 amino 
acids (389 kDa). 
Post-transcriptional regulation of SLC9A3R1 occurs 
via Serines S77-p, S162-p, S339-p, S340-p. 
SLC9A3R1 is also phosphroylated on T95-p. 
SLC9A3R1 has two PDZ (DHR) domains. 
SLC9A3R1 can exist as a homodimer or heterodimer 
with SLC9A3R2. 
Expression 
SLC9A3R1 is expressed in liver, salivary glands, 
kidney, pancreas, trachea, small intestine, stomach, 
prostate and brain. 
Localisation 
SLC9A3R1 is a cytoplasmic protein. SLC9A3R1 
translocates from the cytoplasm to the apical cell 
membrane in a PODXL-dependent manner. 
SLC9A3R1 colocalizes with actin in microvilli-rich 
apical regions of the syncytiotrophoblast. SLC9A3R1 
has been found in microvilli, ruffling membrane and 
filopodia of HeLa cells. SLC9A3R1 is also been 
discovered in lipid rafts of T-cells. 
Subcellular localization is present in cells with apical 
specialized structure such as micorvili and cilia. 
SLC9A3R1 also has a membranous expression in cells 
of non-epithelial origin (astrocytes) and hematopoietic 
stem cells and has been found in membrane rafts in 
lymphocytes and at the rear edge of neutrophils. 
Function 
SLC9A3R1 is a scaffold protein that connects plasma 
membrane proteins with members of the 
ezrin/moesin/radixin family and thereby helps to link 
them to the actin cytoskeleton to regulate their surface 
expression. SLC9A3R1 has been shown to be 
necessary for recycling of internalized ADRB2. 
SLC9A3R1 regulates SLC9A3 as well as its subcellular 
location. SLC9A3R1 is required for cAMP-mediated 
phosphorylation and inhibition of SLC9A3R1. 
SLC9A3R1 interacts with MCC. SLC9A3R1 may 
participate in HTR4 targeting to microvilli. SLC9A3R1 
has been shown to play a role in the WNT signaling 
pathway. 
 
Induction: SLC9A3R1 can be induced by estrogen. 
SLC9A3R1 has been show to have binary interaction 




SLC9A3R1 has been shown to have three natural 
variants. 
Natural variant 110L --> V in NPHLOP2; the mutant 
expressed in cultured renal cells increases the 
generation of cyclic AMP (cAMP) by parathyroid 
hormone (PTH) and inhibits phosphate transport. 
Natural variant 153R --> Q in NPHLOP2; the mutant 
expressed in cultured renal cells increases the 
generation of cAMP by PTH and inhibits phosphate 
transport. 
Natural variant 225E --> K in NPHLOP2; the mutant 
expressed in cultured renal cells increases the 





There is growing evidence SLC9A3R1 plays an 
important role in cancer progression. SLC9A3R1 
functions as an adaptor protein to control cell 
transformation. In addition, recent evidence suggests 
that SLC9A3R1 has a dual role either acting as a tumor 
suppressor when it is localized as the cell membrane or 
as an oncogenic protein when it is localized in the 
cytoplasm (Georgescu et al., 2008). 
Glioblastoma 
Note 
The invasive nature of glioblastoma multiforme 
presents a clinical problem rendering tumors incurable 
by conventional treatment modalities such as surgery, 
ionizing radiation, and temozolomide. 
SLC9A3R1 has been implicated to play a role in 
sustaining glioma cell migration and invasion. 
SLC9A3R1 has been shown to be over-expressed in 
invading glioma cells as compared to the tumor core 
(Kislin et al., 2009). 
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Breast cancer 
Note 
Increased cytoplasmic expression of SLC9A3R1 in 
breast tumors suggests a key role of its localization and 
compartmentalization in defining cancerogenesis, 
progression, and invasion. SLC9A3R1 overexpression 
has been associated with increasing tumor 
cytohistological grade, aggressive clinical behavior, 
unfavorable prognosis, and increased tumor hypoxia. 
Moreover, SLC9A3R1 co-localizes with the oncogenic 
receptor HER2/neu in HER2/neu-overexpressing 
carcinoma and in distant metastases (Mangia et al., 
2009). 
The switch from apical membranous to cytoplasmic 
expression is compatible with a dual role for NHERF1 
as a tumour suppressor or tumour promoter dependent 
on its subcellular localization (Georgescu et al., 2008). 
Cystic fibrosis 
Note 
The inherited disease cystic fibrosis is one of the most 
common chronic lung diseases in children and young 
adults and may lead to an early death. 
Cystic fibrosis transmembrane regulator (CFTR) 
functions as a cAMP-regulated chloride channel, and 
mutations in CFTR are contributory in cystic fibrosis. 
CFTR contains a C-terminal SLC9A3R1 consensus 
sequence affording the two proteins to bind with high 
affinity. Recent experiments have postulated two roles 
for SLC9A3R1 in CFTR function. Guggino, Stanton, 
and coworkers have proposed that NHERF functions as 
a membrane retention signal for CFTR (Moyer et al., 
1999). 
Raghuram et al. suggest that SLC9A3R1 facilitates the 
dimerization of CFTR leading to its full expression of 
chloride channel activity (Raghuram et al., 2001). 
Lastly, ss2-adrenoceptors have been shown to 
physically interact with CFTR Na+/H+ Exchanger 
Regulatory Factor 1 SLC9A3R1 protein. This function 
of SLC9A3R1 could be a new therapeutic target in CF 
patients to facilitate the trafficking of mutated CFTR to 
plasma membrane (Bossard et al., 2011). 
Hypophosphatemia and nephrolithiasis 
Note 
SLC9A3R1 plays an important role in tumor 
phosphorous transport. Inactivating missense mutations 
in SLC9AR1 have been identified in patients with 
hypercalciuria and neprolithiasis (Karim et al., 2008). 
To be noted 
Note 
We acknowledge the support of Michael Northrop for 
scientific illustrations. 
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